Literature DB >> 10374036

Experimental models of hepatic fibrosis in the rat.

S Wasser1, C E Tan.   

Abstract

The rat is a frequently used experimental model in studies involving human disease. We review several methods of inducing hepatic fibrosis and cirrhosis in rats. These include induction by hepatotoxins and hepatocarcinogens such as carbon tetrachloride, dimethylnitrosamine, thioacetamide and furan; the hepatoxin-cum-nutrient, alcohol; a high fat-low choline-low protein diet; immunologic agents such as heterologous serum or bacterial cell wall products; and obstructive jaundice and biliary cirrhosis by common bile duct ligation.

Entities:  

Mesh:

Year:  1999        PMID: 10374036

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  12 in total

1.  Hepatic injury due to combined choline-deprivation and thioacetamide administration: an experimental approach to liver diseases.

Authors:  Hussam Al-Humadi; Stamatios Theocharis; Ismene Dontas; Vasileios Stolakis; Apostolos Zarros; Argyro Kyriakaki; Rafal Al-Saigh; Charis Liapi
Journal:  Dig Dis Sci       Date:  2012-07-10       Impact factor: 3.199

2.  Antifibrotic effects of magnesium lithospermate B on hepatic stellate cells and thioacetamide-induced cirrhotic rats.

Authors:  Yong Han Paik; Young Joon Yoon; Hyun Chul Lee; Man Kil Jung; So Hee Kang; Sook In Chung; Ja Kyung Kim; Jae Yong Cho; Kwan Sik Lee; Kwang Hyub Han
Journal:  Exp Mol Med       Date:  2011-06-30       Impact factor: 8.718

Review 3.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

4.  Exposure of precision-cut rat liver slices to ethanol accelerates fibrogenesis.

Authors:  Courtney S Schaffert; Michael J Duryee; Robert G Bennett; Amy L DeVeney; Dean J Tuma; Peter Olinga; Karen C Easterling; Geoffrey M Thiele; Lynell W Klassen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-01       Impact factor: 4.052

5.  Defective renal autoregulation in the chronic bile duct ligation model of liver failure.

Authors:  Tomchika Maoka; Tetsuya Kawata; Takao Koike; Toshio Mochizuki; Jurgen Schnermann; Seiji Hashimoto
Journal:  Clin Exp Nephrol       Date:  2018-03-07       Impact factor: 2.801

Review 6.  Liver fibrosis.

Authors:  Ramón Bataller; David A Brenner
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

7.  Activation of protein serine/threonine phosphatase PP2Cα efficiently prevents liver fibrosis.

Authors:  Lirui Wang; Xu Wang; Jing Chen; Zhengyi Yang; Liang Yu; Lihong Hu; Xu Shen
Journal:  PLoS One       Date:  2010-12-06       Impact factor: 3.240

8.  The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat.

Authors:  Kum Fai Chooi; Dinesh Babu Kuppan Rajendran; Siew Siang Gary Phang; Han Hui Alden Toh
Journal:  J Vis Exp       Date:  2016-06-17       Impact factor: 1.355

9.  Antifibrotic effects of green tea on in vitro and in vivo models of liver fibrosis.

Authors:  Hye-Kyung Kim; Taik-Hoon Yang; Hong-Yon Cho
Journal:  World J Gastroenterol       Date:  2009-11-07       Impact factor: 5.742

10.  Can apricot kernels fatty acids delay the atrophied hepatocytes from progression to fibrosis in dimethylnitrosamine (DMN)-induced liver injury in rats?

Authors:  Manal K Abdel-Rahman
Journal:  Lipids Health Dis       Date:  2011-07-07       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.